Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
5
Apr |
Pessary Could Prevent Premature Birth In High Risk WomenCategory: Pregnancy / Obstetrics | Leave a Comment |
Premature delivery is the leading cause of death in newborns. However, according to a study published Online First in The Lancet, pregnant women who are at high risk for preterm birth (those with a short cervix) can considerably reduce the risk of delivering their baby prematurely by having a safe, low-cost cervical pessary inserted during the second trimester…
|
17
Mar |
Reducing C-Sections In First-Time Moms: New Labor-Tracking Tool ProposedCategory: Pregnancy / Obstetrics | Leave a Comment |
Researchers have designed a new version of a labor-tracking tool for pregnant women that they predict could reduce the use of hormonal intervention during labor and lower the number of cesarean sections performed on low-risk, first-time mothers…
|
19
Oct |
Study Shows That New DNA Test To Identify Down Syndrome In Pregnancy Is Ready For Clinical UseCategory: Pregnancy / Obstetrics | Leave a Comment |
A new DNA-based prenatal blood test that can strikingly reduce the number of risky diagnostic procedures needed to identify a pregnancy with Down syndrome is ready to be introduced into clinical practice. The test can be offered as early as 10 weeks of pregnancy to women who have been identified as being at high risk for Down syndrome…
|
10
Aug |
Genetic Analysis Of Amniotic Fluid Shows Promise For Monitoring Fetal DevelopmentCategory: Pregnancy / Obstetrics | Leave a Comment |
Researchers have demonstrated the feasibility of focused fetal gene expression analysis of target genes found in amniotic fluid using Standardized NanoArray PCR (SNAP) technology. This analysis could be used to monitor fetal development, enabling clinicians to determine very early in pregnancy whether fetal organ systems are developing normally…
|
17
Jun |
Early Detection Of Neonatal Acidosis Aided By Fetal ElectrocardiogramCategory: Pregnancy / Obstetrics | Leave a Comment |
Researchers at the University of Granada have proved that this method helps to reduce caesarean rate in women in labour with cardiotocographic recordings (CTG) compatible with the risk of loss of fetal wellbeing, and presents more advantages than pulse oximetry…
|
17
Jun |
Fetal Electrocardiogram Helps In Early Detection Of Neonatal AcidosisCategory: Pregnancy / Obstetrics | Leave a Comment |
University of Granada researchers have proved that fetal electrocardiogram (ECG) is the best method for detecting early acidosis and the risk of loss of fetal well being. This method allows to have healthy fetuses, since it shows the effects of lack of oxygen in the heart and brain of the fetus…
|
19
May |
RCOG Release: Electronic Fetal Monitoring Project Launched To Improve Birth Outcomes And Reduce Medical Litigation, UKCategory: Pregnancy / Obstetrics | Leave a Comment |
Improving birth outcomes and reducing medical litigation costs are the aims behind the new Electronic Fetal Monitoring (eFM) project, launched today by the Royal College of Obstetricians and Gynaecologists (RCOG), the Royal College of Midwives (RCM) and e-Learning for Healthcare…
|
27
Apr |
Verinata Health Announces Publication Of Key Data Reporting Non-Invasive Prenatal Diagnostic Test PotentialCategory: Pregnancy / Obstetrics | Leave a Comment |
Verinata Health, Inc., (Verinata) a privately-held company dedicated to maternal and fetal health, announced the publication of study results using its proprietary prenatal test to accurately identify multiple fetal chromosomal abnormalities from maternal blood. All trisomy 21 and trisomy 18 test samples were classified correctly…
|
14
Feb |
Electronic Fetal Heart Rate Monitoring Greatly Reduces Infant MortalityCategory: Pregnancy / Obstetrics | Leave a Comment |
In a study presented at the Society for Maternal-Fetal Medicine’s (SMFM) annual meeting, The Pregnancy Meeting ™, in San Francisco, researchers presented findings that prove that the use of fetal heart rate monitors lowers the rate of infant mortality…
|
13
Jan |
K-V Pharmaceutical Company Updates Status Of New Drug Application For Gestiva™Category: Pregnancy / Obstetrics | Leave a Comment |
K-V Pharmaceutical Company (NYSE: KVa/KVb) issued an update on the status of the U.S. Food and Drug Administration’s review of Hologic, Inc.’s (Hologic) New Drug Application (NDA) for Gestiva™ (hydroxyprogesterone caproate injection) as a treatment for the prevention of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth…